| (Values in U.S. Thousands) | Sep, 2020 | Jun, 2020 | Mar, 2020 | Dec, 2019 | Sep, 2019 |
| Sales | 490 | 330 | 290 | 380 | 350 |
| Sales Growth | +48.48% | +13.79% | -23.68% | +8.57% | +133.33% |
| Net Income | -820 | -770 | -870 | -1,190 | -920 |
| Net Income Growth | -6.49% | +11.49% | +26.89% | -29.35% | +22.03% |
Myos Rens Tech (MYOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
MYOS RENS Technology Inc. is a BioNutrition and BioTherapeutics company which focused on the discovery, development and commercialization of products which improve muscle health and function essential to the management of sarcopenia, cachexia and degenerative muscle diseases. MYOS RENS Technology Inc., formerly known as MYOS Corporation, is based in Cedar Knolls, New Jersey.